Skip to main content
Español

Guides and fact sheets

Reference material about VAERS: where it sits in vaccine safety monitoring, what healthcare providers must report, and printable material you can share.

Government websites

VAERS is co-managed by the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA). These are the agencies and programs that use or complement VAERS data.

  • CDC vaccine safety — how vaccines are monitored after licensing, and what has been found.
  • FDA Center for Biologics Evaluation and Research — licensing and post-market oversight of vaccines.
  • Vaccine Safety Datalink (VSD) — linked health records used to test signals that appear in VAERS.
  • Clinical Immunization Safety Assessment (CISA) — clinical consultation and research on individual cases.
  • National Vaccine Injury Compensation Program — separate from VAERS. Reporting to VAERS is not a claim.

For healthcare providers

People who administer vaccines have duties under the National Childhood Vaccine Injury Act, and are encouraged to report much more widely than the law requires.

  • Reportable events — the Table of Reportable Events Following Vaccination lists the events that must be reported and the time window for each.
  • Contraindications — any event a manufacturer lists as a reason not to give a further dose must be reported.
  • Administration errors — wrong product, wrong dose, wrong route or expired product, whether or not anyone was harmed.
  • Follow-up requests — for reports classed as serious, VAERS staff request medical records and may contact the practice directly.
  • Reporting for a patient — a provider can report on behalf of a patient, and the patient can also report themselves.

Materials and learning tools

  • Printable VAERS-2 form and instructions, for reporting on paper.
  • Posters and handouts for waiting rooms and vaccination clinics.
  • Training material on what to report, and how a report is used.
  • Published studies and summaries based on VAERS data.